OPUS 4 | Search

4 search hits

1 to 4

Sort by

Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status: an analysis from the acute leukemia working party of the EBMT (2021)

High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (2016)

Czerw, Tomasz ; Labopin, Myriam ; Schmid, Christoph ; Cornelissen, Jan J. ; Chevallier, Patrice ; Blaise, Didier ; Kuball, Jürgen ; Vigouroux, Stephane ; Garban, Frédéric ; Lioure, Bruno ; Fegueux, Nathalie ; Clement, Laurence ; Sandstedt, Anna ; Maertens, Johan ; Guillerm, Gaëlle ; Bordessoule, Dominique ; Mohty, Mohamad ; Nagler, Arnon

Impact of CD3+ and CD34+ doses in the mobilized peripheral blood stem cell grafts on the outcome of reduced-intensity conditioning allogenic transplantation from matched unrelated donors for acute myeloid leukemia: an analysis from the Acute Leukemia Working Party of the EBMT (2014)

Czerw, Tomasz ; Labopin, Myriam ; Schmid, Christoph ; Cornelissen, Jan J. ; Chevallier, Patrice ; Blaise, Didier ; Kuball, Jurgen H. ; Milpied, Noel ; Cahn, Jean-Yves ; Lioure, Bruno ; Fegueux, Nathalie ; Clement, Laurence ; Sandstedt, Anna ; Maertens, Johan ; Guillerm, Gaelle ; Bordessoule, Dominique ; Mohty, Mohamad ; Nagler, Arnon

Allogeneic Hematopoietic Cell Transplantation (alloHCT) for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 (MLL/AF4) B-Acute Lymphoblastic Leukemia in first complete remission (CR1): favorable outcome of patients with negative Minimal Residual Disease (MRD) status at transplant. A report from the Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation (ALWP-EBMT) (2017)

1 to 4